title: Utility of Reporting the Percentage of High-grade Prostate Cancer.
authors.affiliation: Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden. Electronic address: lars.egevad@ki.se.
authors.forename: Lars
authors.initials: L
authors.lastname: Egevad
authors.affiliation: Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand.
authors.forename: Brett
authors.initials: B
authors.lastname: Delahunt
authors.affiliation: Aquesta Pathology, Brisbane, Queensland, Australia.
authors.forename: Hemamali
authors.initials: H
authors.lastname: Samaratunga
authors.affiliation: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: John R
authors.initials: JR
authors.lastname: Srigley
mesh_terms: D006801:Humans; D008297:Male; D011467:Prostate; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms
chemical_list: D017430:Prostate-Specific Antigen